Cannabis 101: What are Terpenes?
Terpenes play an important role in the aroma and flavour of a cannabis strain, and they work in synergy with cannabinoids and other cannabis plant compounds to produce psychoactive effects.
US Researchers Begin First Clinical Trials Using Cannabis Products as Migraine Treatment
Researchers in the US have started what is the country’s first double-blind, randomized, placebo-controlled study examining the effect of cannabis products on severe migraine symptoms.
Medicinal cannabis research receives $1.5m boost
A new University of Adelaide trial will explore the use of personalised medicinal cannabis dosing to prevent common and impactful symptoms of treatment in advanced cancer thanks to Federal Government funding of $1.5 million
Science: The ‘Lazy Stoner’ Stereotype Is Nonsense—Marijuana Users Are Actually More Active
Frequent cannabis users engaged in more physical activity than non-current users.
TGA issues new warning to consumers about ordering black market medicinal cannabis online
The Therapeutic Goods Administration (TGA) has issued a new warning to consumers about the risks of buying black market medicinal cannabis products online, stating they may be unsafe, of poor quality or contain a different dose than that claimed on the label. The advice on the TGA website says: “Beware of buying medicines online. It may seem…
Life changing cannabis oil subsidised for severe epilepsy
From May 1, Australians living with a rare form of epilepsy will have access to a medicinal cannabis medicine.
AS SEEN IN: Business News Australia
ECS Botanics plans major expansion of Tasmanian cannabis farm ECS Botanics (ASX: ECS) has submitted plans to the Office of Drug Control to expand its Tasmanian cannabis farm by more than 100 times its current area. If approved, ECS’ cannabis cultivation area would be expanded from 2,500sqm to 320,000sqm an Australian first according to managing…
AS SEEN IN: STOCKHEAD
ECS Botanics’ new subsidiary extends supply agreement for its sun-kissed cannabis flower Just as they have done with fine wine, Aussies are choosing to consume home-grown marijuana rather than foreign imports, and ECS Botanics (ASX:ECS) is stepping up to the plate with its premium dried flower products. ECS’ new Victoria-based subsidiary, Murray Meds, this week extended its…
AS SEEN IN: The Green Fund
Will Australians Turn to the Black Market Amid the Cannabis Shortage? Australians are running out of medical marijuana, and many will have nowhere to turn but the black market. The number of medical cannabis products being approved via the Special Access Scheme B-portal (SAS-B) continues to rise, with February’s numbers hitting an all-time high of over 8,000…
Murray Meds inks supply deal with Releaf Dispensaries
ECS Botanics subsidiary Murray Meds has signed a deal with Melbourne-based Releaf Dispensaries to supply the group with its dried cannabis flower. ECS food and wellness products are already stocked in Releaf’s St Kilda dispensary. The deal is expected to generate around A$590,000 in revenue for ECS over its 18-month term, with the option to…
MURRAY MEDS SIGNS SUPPLY AGREEMENT WITH AUSTRALIAN CANNABINOID COMPANY
Murray Meds to supply medicinal cannabis dried flower, concentrate and final dose oils to Australian cannabinoid company The customer distributes premium medicinal cannabinoid products and services ECS shareholders approved the acquisition of 100% of Murray Meds on 2 March, 2021 with settlement to occur in the near term ECS Botanics Holdings Ltd (ASX: ECS or…
ABC Radio: ECS Botanics Interview
Click here to listen to Managing Director, Alex Keach interview with Laurissa Smith on Tasmanian Country Hour about our new major medicinal cannabis project.
